BBA
GRCL

Baker Bros. Advisors’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History

Baker Bros. Advisors’s Portfolio GRCL Stock Details GRCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,080,000
Closed -$20.9M – 92
2023
Q4 		$20.9M Buy
2,080,000
+1,080,000
+108% +$10.8M 0.24% 38
2023
Q3 		$2.88M Hold
1,000,000
– – 0.02% 77
2023
Q2 		$3.81M Buy
+1,000,000
New +$3.81M 0.02% 79